FDA approves new antibiotic for complicated urinary tract infections
The Food and Drug Administration yesterday approved an antibacterial drug to treat adults with complicated urinary tract infections, including kidney infections caused by susceptible gram-negative microorganisms who have limited or no alternative treatment options. The drug’s labeling includes a warning regarding a higher all-cause mortality rate observed in patients treated with the new drug compared to those treated with other antibiotics in a trial involving critically ill patients with multidrug-resistant gram-negative bacterial infections.
Related News Articles
Headline
The Consumer Product Safety Commission yesterday announced it is modernizing the National Electronic Injury Surveillance System, the national database for…
Headline
A Centers for Disease Control and Prevention report released July 16 found that wastewater surveillance failed to detect an internationally circulating measles…
Headline
Ryane Jackson, vice president of Community Health Network at Memorial Hermann Health System, explains how the system is creating seamless connections between…
Headline
The Department of Health and Human Services and the Centers for Medicare & Medicaid Services July 8 launched a voluntary pledge that hospitals can…
Headline
The Social Security Administration today announced actions to help parents enroll newborns in Trump Accounts, which are investment accounts for children under…
Perspective
The adoption of the Declaration of Independence on July 4, 1776, marked a pivotal turn for colonists, from a fight for rights as British subjects to the…